Equities

Indivior PLC

INDV:LSE

Indivior PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)1,337.00
  • Today's Change-15.00 / -1.11%
  • Shares traded1.68m
  • 1 Year change-9.78%
  • Beta-0.2380
Data delayed at least 20 minutes, as of May 17 2024 15:16 BST.
More ▼

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,093901791
OPERATING EXPENSES
Cost of revenue total177152127
Selling, general and admin. expenses, total530450393
Depreciation/amortization131113
Unusual expense(income)2743082.00
Other operating expenses, total(3)(7)--
Total operating expense1,097986587
Operating income(4)(85)204
Other, net(8)(6)--
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1.00(95)190
Provision for income taxes4.00(20)(15)
Net income after taxes(3)(75)205
Minority interest------
Net income before extra. Items(3)(75)205
Total extraordinary items5.0022--
Net income2.00(53)205
Inc.avail. to common excl. extra. Items(3)(75)205
Inc.avail. to common incl. extra. Items2.00(53)205
EPS RECONCILIATION
Basic/primary weighted average shares137139146
Basic/primary eps excl. extra items(0.02)(0.54)1.41
Basic/primary eps incl. extra items0.01(0.38)1.41
Dilution adjustment------
Diluted weighted average shares142139154
Diluted eps excl. extra items(0.02)(0.54)1.33
Diluted eps incl. extra items0.01(0.38)1.33
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental302218
SUPPLEMENTAL INCOME
Depreciation, supplemental161413
Total special items2743082.00
NORMALISED INCOME
Normalized income before taxes275213192
Effect of special items on income taxes(63)(75)(40)
Income tax excluding impact of special items(59)(95)(55)
Normalized income after tax334308247
Normalized income avail. to common334308247
Basic normalized EPS2.432.221.70
Diluted normalized EPS2.362.221.60
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.